Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
| DUOPHARMA BIOTECH BERHAD |
Particulars of substantial Securities Holder
| Name | PERMODALAN NASIONAL BERHAD |
| Address |
LEVEL 91, MENARA MERDEKA 118, PRESINT MERDEKA 118
KUALA LUMPUR 50118 Wilayah Persekutuan Malaysia. |
| Company No. | 197801001190 (38218-X) |
| Nationality/Country of incorporation | Malaysia |
| Descriptions (Class) | Ordinary shares |
Details of changes
| No | Date of change | No of securities |
Type of Transaction | Nature of Interest |
| 29 Apr 2026 | 10,000,000 |
Disposed | Direct Interest | |
| Name of registered holder | PERMODALAN NASIONAL BERHAD | |||
| Address of registered holder | LEVEL 91, MENARA MERDEKA 118, PRESINT MERDEKA 118, 50118 KUALA LUMPUR | |||
| Description of "Others" Type of Transaction | ||||
| Circumstances by reason of which change has occurred | Disposal of 10,000,000 shares by Permodalan Nasional Berhad on 29 April 2026. |
| Nature of interest | Direct Interest |
| Direct (units) | 414,281,114 |
| Direct (%) | 43.067 |
| Indirect/deemed interest (units) | |
| Indirect/deemed interest (%) | |
| Total no of securities after change | 414,281,114 |
| Date of notice | 29 Apr 2026 |
| Date notice received by Listed Issuer | 04 May 2026 |
Announcement Info
| Company Name | DUOPHARMA BIOTECH BERHAD |
| Stock Name | DPHARMA |
| Date Announced | 04 May 2026 |
| Category | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 |
| Reference Number | CS2-04052026-00020 |